CUSIP 92840H400COMVTGNQ4 2025
34 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 3.06M | $2.03M |
| 2 | Tcg Crossover Management, LLC | 2.68M | $1.77M |
| 3 | Vanguard Group Inc | 1.82M | $1.21M |
| 4 | Adar1 Capital Management, LLC | 623.6K | $412.7K |
| 5 | Jane Street Group, LLC | 527.1K | $348.9K |
| 6 | Ikarian Capital, LLC | 519.1K | $343.6K |
| 7 | Blackrock, Inc. | 422.8K | $279.8K |
| 8 | Geode Capital Management, LLC | 352.8K | $233.6K |
| 9 |
| 4 | Feb 17, 2026 | Stempoint Capital LP | 13G/A | 1.5% | 616.7K | SEC |
| 5 | Feb 17, 2026 | Orbimed Advisors LLC | 13G/A | 4.2% | 14.20T | SEC |
| 6 | Feb 13, 2026 | Nantahala Capital Management, LLC | 13G/A | 4.7% | 1.95M | SEC |
| 7 | Jan 30, 2026 | The Vanguard Group | 13G/A | 4.6% | 1.82M | SEC |
| 8 | Nov 14, 2025 | Great Point Partners, LLC | 13G/A | 6.3% | 2.06M | SEC |
| 9 | Nov 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 10.0% | 3.19M | SEC |
| 10 | Nov 14, 2025 | Orbimed Advisors LLC | 13G | 5.3% | 14.20T | SEC |
See the full Schedule 13D/13G history for Vistagen Therapeutics Inc.
Unlock full history| Luminus Management LLC |
| 350.0K |
| $231.7K |
| 10 | Susquehanna International Group, LLP | 334.8K | $221.6K |